Cord Blood CD34+ Stem/Progenitor Cells, Single Donor, Frozen
Human cord blood CD34+ stem and progenitor cells are positively selected using immunomagnetic anti-CD34 (clone QBEND10) microbeads from the mononuclear cell fraction. Isolated cells are characterized by flow cytometry prior to cryopreservation to ensure a highly pure and viable cell population.
Cells were obtained using Institutional Review Board (IRB) approved consent forms and protocols.
Since our founding in 2010, CGT Global has pursued our mission to transform healthcare as we accelerate cell and gene therapy research and clinical trials, streamline the commercialization of new treatments, and map the last mile to patient access to these life-changing remedies. By innovating each stage in the cycle; development, commercialization, and delivery, we reduce the overall cost of the care and multiply access points so that millions can receive cutting edge, life-saving gene and cell therapies.
Description
CD34 is a glycosylated transmembrane protein and represents a well-established marker for human hematopoietic stem and progenitor cells in peripheral blood, bone marrow, and cord blood. CD34+ cells are self-renewing, multipotent stem cells that give rise to all blood cells of the immune system through a process called hematopoiesis. As hematopoietic stem cells progress through hematopoiesis they generate the myeloid (monocytes, macrophages, granulocytes, megakaryocytes, dendritic cells, erythrocytes) and lymphoid (T cells, B cells, NK cells) lineages. The highly specialized cells that arise from hematopoietic stem cells work collaboratively in defending the body against infection and disease.
Additional information
| Anticoagulant | |
|---|---|
| Format | |
| Grade | |
| Species | |
| Cell and Tissue Source | |
| Disease State | |
| Donor Attributes |
Product Information Sheet
Cord Blood CD34+ Stem/Progenitor Cells, Single Donor, Frozen
Material Safety Data Sheet
Halkias et al. (2015) Conserved and Divergent Aspects of Human T-cell Development and Migration in Humanized Mice. Immunol Cell Biol 1-11. doi:10.1038/icb.2015.38.
Cleyrat et al. (2017) Gene Editing Rescue of a Novel MPL Mutant Associated with Congenital Amegakaryocytic Thrombocytopenia. Blood Advances 1: 1815-1826. doi.org/10.1182/bloodadvances.201600291.
Takahashi et al. (2018) Enhanced Antibody Responses in a Novel NOG Transgenic Mouse with Restored Lymph Node Organogenesis. Front. Immunol 1(17). doi.org/10.3389/fimmu.2017.02017.
Ito et al. (2020) Bovine β-Lactoglobulin-Induced Passive Systemic Anaphylaxis Model Using Humanized NOG hIL-3/hGM-CSF Transgenic Mice. Int Immunol. DOI: 10.1093/intimm/dxaa067.
Related products
-
Whole Blood, Fresh, ACD-A
Select options This product has multiple variants. The options may be chosen on the product page -
Whole Blood Vacutainer Tube Collections, Fresh, EDTA
Select options This product has multiple variants. The options may be chosen on the product page -
Bone Marrow Mesenchymal Stem Cells, Frozen
Select options This product has multiple variants. The options may be chosen on the product page -
Whole Blood, Fresh, CP2D
Select options This product has multiple variants. The options may be chosen on the product page